1. McLoughlin, Hayley S, Moore, Lauren R, Paulson, Henry L. 2019. Pathogenesis of SCA3 and implications for other polyglutamine diseases. In Neurobiology of disease, 134, 104635. doi:10.1016/j.nbd.2019.104635. https://pubmed.ncbi.nlm.nih.gov/31669734/
2. Raposo, Mafalda, Hübener-Schmid, Jeannette, Tagett, Rebecca, Costa, Maria do Carmo, Lima, Manuela. 2024. Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease. In Neurobiology of disease, 193, 106456. doi:10.1016/j.nbd.2024.106456. https://pubmed.ncbi.nlm.nih.gov/38423193/
3. Déglon, N. 2024. Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3. In Revue neurologique, 180, 378-382. doi:10.1016/j.neurol.2024.03.003. https://pubmed.ncbi.nlm.nih.gov/38580500/
4. Schuster, Kristen H, Zalon, Annie J, DiFranco, Danielle M, Guan, Yuanfang, McLoughlin, Hayley S. 2024. ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 1359-1372. doi:10.1016/j.ymthe.2024.02.033. https://pubmed.ncbi.nlm.nih.gov/38429929/
5. Zhu, Rongxuan, Gires, Olivier, Zhu, Liqun, Lu, Zhimin, Wang, Hongxia. 2019. TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling. In Nature communications, 10, 2863. doi:10.1038/s41467-019-10739-3. https://pubmed.ncbi.nlm.nih.gov/31253779/
6. Wu, Longxiang, Ou, Zhenyu, Liu, Peihua, Wang, Yongjie, Tang, Jianing. 2023. ATXN3 promotes prostate cancer progression by stabilizing YAP. In Cell communication and signaling : CCS, 21, 152. doi:10.1186/s12964-023-01073-9. https://pubmed.ncbi.nlm.nih.gov/37349820/